Cerebellar lithium toxicity: A review of recent literature and tentative pathophysiology;TOXICITE CEREBELLEUSE DU LITHIUM: REVUE DE LA LITTERATURE RECENTE ET HYPOTHESES PHYSIOPATHOLOGIQUES

Therapie

Volumn 51, Issue 2, 1996, Pages 101-106

  Grignon, S ^a   Bruguerolle, B ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

calcium homeostasis; cerebellar Purkinje cells; cerebellar syndrome; cytokines; lithium neurological sequelae

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

BRAIN TOXICITY; CALCIUM HOMEOSTASIS; DRUG BLOOD LEVEL; HUMAN; NEUROPATHOLOGY; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PURKINJE CELL; REVIEW;

CEREBELLAR DISEASES; DRUG ADMINISTRATION SCHEDULE; HUMANS; LITHIUM; PURKINJE CELLS;

EID: 0029949773     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Okusa MD, Crystal LJT. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994; 97: 383-389.
2. Finley P.R., Warner M.D., Peabody C.A. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995; 29:172-191.
3. Adityanjee. The syndrome of irreversible lithium effectuated neurotoxicity. J Neurol Neurosurg Psychiatry 1987; 50: 1246-1247.
4. Bell AJ, Cole A, Eccleston D, Ferrier IN. Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993; 162: 689-692.
5. Sansone MEG, Ziegler DK. Lithium toxicity : a review of neurologic complications. Clin Neuropharmacol 1985; 8: 242-248.
6. Tesio L, Porta GL, Messa E. Cerebellar syndrome in lithium poisoning: a case of partial recovery. J Neurol Neurosurg Psychiatry 1987; 50: 235.
7. Nagaraja D, Taly AB, Sahu RN et al. Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosurg 1987; 89: 31-34.
8. Verdoux H, Bourgeois M. A case of lithium neurotoxicity with irreversible cerebellar syndrome. J Nerv Ment Dis 1990; 178: 761-762.
9. Pelletier J, Habib M, Pellissier JF et al. Séquelles neurologiques de l'association neuroleptiques-lithium: rôle de l'hyperthermie. Rev Med Int 1991; 12: 187-191.
10. Naramoto A, Koizumi N, Itoh N. Shigematsu H. An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome. Acta Pathol Jpn 1993; 43: 55-58.
11. Manto M, Godaux E, Seillier M et al. Syndrome cérebelleux secondaire à une intoxication au lithium: étude cinématique et électromyographique de deux cas. Rev Neurol (Paris) 1994; 150: 467-470.
12. Schneider JA, Mirra SS. Neuropathologic correlates of persistent neurologie deficits in lithium intoxication. Ann Neurol 1994; 36: 928-931.
13. Verdoux H, Bourgeois M. Séquelles neurologiques irréversibles induites par le lithium. Encéphale 1991; XVII: 221-224.
14. Strayhorn JM, Nash JL. Severe neurotoxicity despite "therapeutic" serum lithium levels. Dis Nerv Sys 1977; 38: 107-111.
15. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981; 138: 818-821.
16. Rittmannsberger H, Leblhuber F. Asterixis induced by carbamazepine therapy. Biol Psychiatry 1992; 32: 364-368.
17. Blake LM, Marks RC, Luchins DJ. Reversible neurologic symptoms with clozapine and lithium. J Chn Psychophamacol 1992; 12: 297-299.
18. Garcia G, Crismon ML, Dorson PG. Seizures in two patients after the addition of lithium to a clozapine regimen. J Clin Psychophamacol 1994; 14: 426-428.
19. Tanquary J. Lithium neurotoxicity at therapeutic levels in an AIDS patient. J Nerv Ment Dis 1994; 181: 518-9.
20. PeifferJ. Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication. Arch Psychiatr Nervenkr 1981; 231: 41-60.
21. Lefkowitz D, Ford CS, Rich C et al. Cerebellar syndrome following neuroleptic induced heat stroke. J Neurol Neurosurg Psychiatry 1983: 46: 183-185.
22. Lee S, Merriam A, Kim TS et al. Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury. J. Neurol Neurosurg Psychiatry 1989; 52: 387-391.
23. ++ signaling in the brain. J Neurochem 1995; 64: 953-960.
24. Nahorsky SR, Ragan IC, Challiss RAJ. Lithium and the phosphoinositide cycle: an exemple of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991; 12: 297-303.
25. Dixon JF, Hokin LE. Lithium stimulates accumulation of second-messenger inositol 1,4,5-triphosphate and other inositol phosphates in mouse pancreatic minilobule withot inositol supplementation. Biochem J 1994; 304: 251-258.
26. Dixon JF, Los GV, Hokin LE. Lithium stimulates glutamat "release" and inositol 1,4,5-triphosphate accumulation VI. activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices, Proc Natl Acad Sci USA 1994; 91 8358-8362.
27. De Schutter E. Cerebellar long term-depression migh normalize excitation of Purkinje cells: a hypothesis. Trend Neurosci 1995: 18: 291-295.
28. Brorson JR, Manzolillo PA, Gibbons SJ et al. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci 1995; 15: 4515-4524
29. Culic M, Saponjic J, Jankovic B, et al. Amphetamine and haloperidol modulatory effects on Purkinje cell activity and on EEG power spectra in the acute rat model of epilepsy. Neurosci Lett 1994; 182: 259-262.
30. Lavé S, Parnet P, Goujon E et al. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol Brain Res 1994 27: 157-162.
31. Breder CD, Hazuka C, Ghayur T et al. Regional induction of tumor necrosis factor α in the mouse brain after systemic lipopolysaccharide administration. Proc Nail Acad Sci USA 1994; 91: 11393-11397.
32. Holliday J, Parsons K, Curry J et al. Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res 1995; 673: 141-148.
33. Beyaert R, Heyninck K, Boeykens F et al. Enhancement of tumor necrosis factor cytotoxicity is associated with increased inositol phosphate accumulation. J Immunol 1993; 151: 291-300.